ROPIVACAINE HYDROCHLORIDE ANHYDROUS
UNII 35504LBE2T

Substance Identification & Data

This profile provides standardized clinical and technical data for Ropivacaine Hydrochloride Anhydrous, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 35504LBE2T.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 98717-15-8 and the RxNorm Concept ID (RxCUI) 2198974. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

35504LBE2T

CAS Registry Number

98717-15-8

RxNorm Concept ID

2198974

Detailed Substance Profile

Preferred Name

ROPIVACAINE HYDROCHLORIDE ANHYDROUS

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

35504LBE2T

The specific atomic composition represented as a molecular structure string.

InChIKey

C17H26N2O.ClH

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

NDNSIBYYUOEUSV-RSAXXLAASA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C218272

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

175804

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

Cl.C(Nc1c(cccc1C)C)([C@H]2N(CCC)CCCC2)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ropivacaine Hydrochloride Anhydrous. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.